The Goldman Sachs Group Trims Singular Genomics Systems (NAS

Singular Genomics Systems (NASDAQ:OMIC – Free Report) had its price objective cut by The Goldman Sachs Group from $0.95 to $0.85 in a research note published on Monday, Benzinga reports. They currently have a neutral rating on the stock. Singular Genomics Systems Stock Performance OMIC opened at $0.43 on Monday. The stock has a market […]

Related Keywords

Elin Glezer , , Singular Genomics Systems Inc , Goldman Sachs Group , Balyasny Asset Management , Proshare Advisors , Capital Management , Millennium Management , Singular Genomics Systems Company Profile , Singular Genomics Systems , Free Report , Genomics Systems , Get Free Report , Singular Genomics , Asset Management , Share Advisors , Singular Genomics Systems Daily , Nasdaq Omic , Comic , Medical , Lower Price Target , The Goldman Sachs Group Inc ,